Related Experiment Video

Updated: Aug 19, 2026

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

[Genetic engineering in clinical pathology]

I Kawabata1

  • 1Department of Clinical Medicine, Asahikawa Medical College.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 1, 1994
PubMed

Insights

CD36 deficiency on platelets may stem from transcriptional control, not just genetic mutations. This study investigated CD36 mRNA expression, revealing altered patterns in megakaryocytes, suggesting unique transcription mechanisms.

Area of Science:

  • Molecular Biology
  • Hematology
  • Immunology

Background:

  • CD36 is a crucial glycoprotein found on platelets, monocytes, and endothelial cells.
  • Understanding CD36 deficiency mechanisms is vital for platelet function and immune response research.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying CD36 deficiency on the platelet membrane.
  • To analyze CD36 messenger RNA (mRNA) expression and its transcriptional regulation in platelets.

Main Methods:

  • Reverse Transcription Polymerase Chain Reaction (RT-PCR) was employed to examine CD36 mRNA expression.
  • Agarose gel electrophoresis was used to analyze PCR product size and quantity.
  • Restriction enzyme digestion (Sau96I) was performed to assess variations in PCR products.

Main Results:

  • Reduced CD36 mRNA expression (few products of normal size) was observed in specific cases (3, 5, and 6).
  • Multiple restriction enzyme patterns were detected after Sau96I digestion across all analyzed cases.
  • These findings indicate potential alterations in CD36 gene transcription.

Conclusions:

  • Transcriptional control appears to significantly influence CD36 molecule expression on the platelet membrane.
  • The transcription of CD36 mRNA in megakaryocytes may involve different mechanisms compared to monocytes.
  • Further research is warranted to elucidate the precise regulatory pathways affecting CD36 expression in platelets.

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...